glp-1 and muscle mass Study finds receptor agonists target fat over for weight loss Do GLP-1 drugs shrink your

Efficacy and safety of once-weekly efpeglenatide monotherapy versus placebo in type 2 diabetes: the AMPLITUDE-M randomized controlled trial

The following search terms were used: (exenatide OR liraglutide OR albiglutide OR dulaglutide OR lixisenatide OR semaglutide OR tirzepatide OR GLP-1 RAs OR Glucagon-like peptide-1 receptor agonist) AND (acute pancreatitis) AND (case report OR case series)

The baseline characteristics before placebo treatment according to treatment sequence, i.e., placebo or dulaglutide first, were similar between the 2 groups

Semaglutide belongs to a class of drugs called GLP-1 receptor agonists

While prescribing GLP-1 drugs addresses obesity one patient at a time, Sceppa says, a broader public health approach to reach many people at scale is essential